Tranexamic acid in cardiac surgery: Is there a cause for concern?

Critical Care

Volumn 14, Issue 5, 2010, Pages

  Royston, David ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMINOCAPROIC ACID; APROTININ; TRANEXAMIC ACID;

BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; BRAIN VASOSPASM; CANADA; CENTRAL NERVOUS SYSTEM; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG APPROVAL; DRUG EFFICACY; DRUG INDICATION; DRUG MARKETING; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EUROPE; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEMOSTASIS; HUMAN; MORBIDITY; MORTALITY; NORTH AMERICA; NOTE; PATIENT SELECTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEIZURE; ANIMAL; POSTOPERATIVE HEMORRHAGE;

ANIMALS; APROTININ; CARDIAC SURGICAL PROCEDURES; HUMANS; POSTOPERATIVE HEMORRHAGE; TRANEXAMIC ACID;

EID: 80052782513     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9227     Document Type: Note

References (13)

1. Sander M, Spies CD, Martiny V, Rosenthal C, Wernecke KD, von Heymann C. Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis. Crit Care 2010, 14:R148. 10.1186/cc9216, 20682059.
2. EMA. , http://www.ema.europa.eu/pdfs/human/press/pr/10757010en.pdf
3. Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL. The dose-response relationship of tranexamic acid. Anesthesiology 1995, 82:383-392. 10.1097/00000542-199502000-00009, 7856897.
4. McIlroy DR, Myles PS, Phillips LE, Smith JA. Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis. Br J Anaesth 2009, 102:168-178. 10.1093/bja/aen377, 19151047.
5. Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ 2009, 180:183-193. 2621296, 19050037.
6. Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Anesth Analg 2009, 110:21-29. 10.1213/ANE.0b013e3181c0ea6d, 19910626.
7. Fodstad H, Forssell A, Liliequist B, Schannong M. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial. Neurosurgery 1981, 8:158-165. 10.1227/00006123-198102000-00004, 7010203.
8. Barker JL, Nicoll RA, Padjen A. Studies on convulsants in the isolated frog spinal cord. I. Antagonism of amino acid responses. J Physiol Lond 1975, 245:521-536. 1330803, 1079871.
9. Furtmüller R, Schlag MG, Berger M, Hopf R, Huck S, Sieghart W, Redl H. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(A) receptor antagonistic effect. J Pharmacol Exp Ther 2002, 301:168-173. 10.1124/jpet.301.1.168, 11907171.
10. Feffer SE, Parray HR, Westring DW. Seizure after infusion of aminocaproic acid. JAMA 1978, 240:2468. 10.1001/jama.240.22.2468, 101682.
11. Martin K, Wiesner G, Breuer T, Lange R, Tassani P. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008, 107:1783-1790. 10.1213/ane.0b013e318184bc20, 19020118.
12. Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M. High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010, 110:350-353. 10.1213/ANE.0b013e3181c92b23, 19996135.
13. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987, 2:1289-1291. 10.1016/S0140-6736(87)91190-1, 2446091.